Results 141 to 150 of about 92,710 (320)
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulization [PDF]
James Hall
openalex +1 more source
Abstract Sympathetic restraint in exercising muscle is currently viewed as required to prevent ‘excess’ vasodilatation from exceeding the cardiac output (Q̇${\dot{Q}} $) response, even in submaximal exercise. Certainly, muscle vasodilatory capacity dictates the requirement for sympathetic restraint when cardiac pumping capacity is approached.
Patrick J. Drouin+4 more
wiley +1 more source
Effects of beta-adrenergic receptor agonist and low environmental temperature on the immune system of growing lambs [PDF]
Y. Z. Li+2 more
openalex +1 more source
Beta-adrenergic agonists increase maximal output of oxidative phosphorylation in bovine satellite cells1 [PDF]
Renae L Sieck+6 more
openalex +1 more source
Abstract The ability to increase cardiac output during dynamic exercise is paramount for the ability to maintain workload performance. Reflex control of the cardiovascular system during exercise is complex and multifaceted involving multiple feedforward and feedback systems.
Donal S. O'Leary, Joseph Mannozzi
wiley +1 more source
In vivo beta-adrenergic agonist effects on peripheral blood mononuclear cell and soluble adhesion molecule expression in hypertension [PDF]
P. C. Mills
openalex +1 more source
Abstract Adipose tissue has an established endocrine function through the secretion of adipokines. However, a role for bioactive metabolites and lipids, termed metabokines and lipokines, is emerging in adipose tissue‐mediated autocrine, paracrine and endocrine signalling and inter‐organ communication. Traditionally seen as passive entities, metabolites
Anna Malicka+3 more
wiley +1 more source
Immunoaffinity Column as Sample Cleanup Method for Determination of the Beta-Adrenergic Agonist Ractopamine and Its Metabolites [PDF]
Weilin L. Shelver, David J. Smith
openalex +1 more source